Halaven, also known as eribulin, is a chemotherapy drug used to treat certain types of advanced breast cancer. It works by interfering with the growth and spread of cancer cells in the body. Halaven is typically prescribed when other treatments have not been effective or have stopped working.

It is important to follow your healthcare provider’s instructions carefully when taking Halaven. This medication is administered through an intravenous infusion, usually once every 21 days. Your healthcare team will monitor you closely during and after treatment to ensure that you are responding well to the medication and to manage any potential side effects.

Common side effects of Halaven may include fatigue, nausea, hair loss, and decreased appetite. It is important to communicate with your healthcare provider about any side effects you may experience, as they can provide guidance on how to manage them effectively.

As with any medication, there are risks associated with taking Halaven. It is important to discuss your medical history and any other medications you are taking with your healthcare provider before starting treatment with Halaven. They can help determine if this medication is the right choice for you and monitor for any potential interactions.

Overall, Halaven can be an effective treatment option for individuals with advanced breast cancer. By working closely with your healthcare team and following their guidance, you can help maximize the benefits of this medication while minimizing any potential risks.